Down Syndrome Patients at Greater Risk of Complications After Hip or Knee Replacement

Translate to Spanish or other 102 languages!

 In a new study, a team of researchers at Yale School of Medicine's Department of Orthopedics and Rehabilitation say total hip and knee arthroplasty carries additional risks for this population. Image for illustration purposes
In a new study, a team of researchers at Yale School of Medicine’s Department of Orthopedics and Rehabilitation say total hip and knee arthroplasty carries additional risks for this population. Image for illustration purposes
- Advertisement -

By Yale School of Medicine

People with Down syndrome (DS) are increasingly being considered for procedures like joint replacements. In a new study, a team of researchers at Yale School of Medicine’s Department of Orthopedics and Rehabilitation say total hip and knee arthroplasty carries additional risks for this population.

The average lifespan of people with DS increased from 25 years in 1983 to 49 years in 1997 (Yang et al, 2002). As a result, more people with DS are being considered for total hip arthroplasty (THA) and total knee arthroplasty (TKA). “Currently, there is little to no scientific literature examining outcomes in this patient population,” said Scott Halperin, a medical student at Yale School of Medicine and lead author of the study. “We believe it is important to examine the risks associated with this common procedure.”

- Advertisement -

Using data from a large national administrative claims data set, researchers compared patients with DS undergoing both procedures with matched controls. Using multivariable logistic regression, they found patients with DS had no additional risk of surgical revisions compared to controls – but the DS patients experienced significantly greater odds of other complications.

For patients undergoing THA, the team found patients with DS experienced 2.4 times greater odds of any adverse events, including 7.5 times greater odds of sepsis, 5.3 times greater odds of acute kidney injury, and 8.9 times greater odds of pneumonia.

For patients undergoing TKA, patients with DS experienced 2.5 times greater odds of any adverse events, including 7.1 times greater odds of sepsis, 3.4 times greater odds of acute kidney injury, and 8.3 times greater odds of pneumonia.

The team hopes its findings will contribute to safer orthopaedic procedures for patients in this population. “The goal of our study was to shed light on these adverse events both for physicians and for future research directions,” Halperin said.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -